-
Coffee with a view: tourists flock to Starbucks overlooking North Korea
-
EU top court upholds record 4.1 bn euro Google fine
-
German coalition agrees on reform package in key breakthrough
-
Italy name two debutants to face Japan in Nations Championship opener
-
France recall record try scorer Penaud for All Blacks Test
-
Wallabies' Schmidt rules out another coaching job
-
Seoul's Kospi tanks as Asia tech firms suffer another blow
-
India asks Meta to hold WhatsApp username rollout over fraud fears
-
'Outstanding' Love to start at fly-half for All Blacks against France
-
Deadly Russian barrage on Kyiv kills at least 13
-
Campbell back from four years in Wallabies wilderness to face Ireland
-
Next indirect US-Iran talks after Khamenei funeral: mediators
-
Migrants pick up pieces back home after fleeing South Africa
-
Reviving Montenegro's 'ancient' olive tree
-
Farrell names Leinster-heavy Ireland side to face Wallabies
-
Resource rich PNG leaving its Pacific people behind: World Bank
-
Fearing Russian strike, Kyiv's Holodomor museum evacuates exhibits
-
Papal envoy presides over first Vietnam beatification rite
-
Germany's energy-hungry small firms struggle with green shift
-
LeBron James praises Balogun after 'Silencer' celebration
-
Pochettino says Balogun foul 'never' a red card as suspension looms
-
Farrell names Leinster-heavy side to face Wallabies
-
Campbell back after four years in Wallabies team to face Ireland
-
Most Asia markets down as tech firms take fresh blow
-
Kane saves England as USA, Belgium reach last 16
-
South Korean school baseball team suspended over 'Tank Day' chants
-
Budding chefs cook up new career at China's BBQ academy
-
Ceuzany, Cape Verde's golden voice with volcanic emotion
-
One stitch at a time: Artist's mission to recreate the Bayeux Tapestry
-
Balogun scores and sees red as US beat Bosnia 2-0
-
Deadly Russian barrage pounds Ukraine capital
-
EU top court to rule on record 4.1 bn euro Google fine
-
Belgium coach salutes Tielemans after World Cup rescue act
-
'Job forever': trade schools are all the rage in the AI era
-
Cracking open a can of cannabis -- America's new pastime (for now)
-
Celtics reportedly trading Brown to Sixers in NBA blockbuster
-
Russia strikes Ukraine capital with missiles and drones, wounds five
-
Kane saves England after DR Congo scare; Belgium comeback stuns Senegal
-
Belgium late show floors Senegal at World Cup
-
Celtics to trade Jaylen Brown to 76ers for Paul George: report
-
Harry Kane: England's World Cup saviour
-
Streamex is making digital gold accessible
-
US actor Danny Glover says he has Alzheimer's
-
Mixed US auto sales in Q2 amid high gas prices
-
Trump sees progress as US, Iran hold Qatar talks
-
Pistons forward Harris reportedly headed to Spurs
-
Djokovic, Sinner into Wimbledon third round, Andreeva stunned
-
Jovial Djokovic dismantles Tsitsipas to reach Wimbledon third round
-
Spurs agree club record £100 mn move for Newcastle's Tonali - reports
-
US stocks retreat to open Q3 ahead of June jobs data
New Zealand approves medicinal use of 'magic mushrooms'
New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called "magic mushrooms".
Deputy Prime Minister David Seymour said rules had been relaxed so psilocybin could be used to treat certain types of depression.
Psilocybin is a naturally occurring psychedelic compound found in some species of mushroom and can cause hallucinations and an altered state of mind.
"Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression," Seymour said.
"This is huge for people with depression who've tried everything else and are still suffering.
"If a doctor believes psilocybin can help, they should have the tools to try."
There will be tight rules for prescribing the drug.
Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.
Party drugs such as as MDMA and magic mushrooms are increasingly being used in mainstream medical settings, helping treat post-traumatic stress disorder and depression.
Australia approved the medicinal use of psilocybin in 2023.
B.Baumann--VB